Arkolith/Insider Trading/TXMD/Form 4/A

Walker Marlan D

Chief Executive OfficerTherapeuticsMD, Inc. (TXMD) · full profile →Form 4/A · filed May 4, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3K
Net Open-Market Flow
-$3K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 26, 2023Option exercise(M)2K—$012K
Apr 26, 2023Option exercise(M)1K—$014K
Apr 26, 2023Sell(S)692$3.64$3K12K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 26, 2023Option exercise(M)1K—$00
Apr 26, 2023Option exercise(M)2K—$03K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001209191-23-027361) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML

Keep exploring

Connected pages for TherapeuticsMD, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp